Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

ÀÚ°£ÀüÁõÀÇ »ýÈ­ÇÐÀû Ç¥Áö¹°Áú°ú À¯¿ë¼º Biological markers and its significance in preeclamptic patients

´ëÇÑ»êºÎÀΰúÇÐȸÁö 1999³â 42±Ç 12È£ p.2782 ~ 2786
ÀÌÁ¾°Ç, ÀÌÇü±Ù, ±è¿ë¿í, Á¤´ë¿µ, ÀÌÁ¾½Â, ±è»çÁø, ³ªÁ¾±¸, ±è¼öÆò,
¼Ò¼Ó »ó¼¼Á¤º¸
ÀÌÁ¾°Ç ( Lee Jong-Kun ) 
°¡Å縯´ëÇб³ ÀÇ°ú´ëÇÐ »êºÎÀΰúÇб³½Ç

ÀÌÇü±Ù ( Lee Hyung-Keun ) 
°¡Å縯´ëÇб³ ÀÇ°ú´ëÇÐ »êºÎÀΰúÇб³½Ç
±è¿ë¿í ( Kim Yong-Wook ) 
°¡Å縯´ëÇб³ ÀÇ°ú´ëÇÐ »êºÎÀΰúÇб³½Ç
Á¤´ë¿µ ( Chung Dae-Young ) 
°¡Å縯´ëÇб³ ÀÇ°ú´ëÇÐ »êºÎÀΰúÇб³½Ç
ÀÌÁ¾½Â ( Yi Chong-Seung ) 
°¡Å縯´ëÇб³ ÀÇ°ú´ëÇÐ »êºÎÀΰúÇб³½Ç
±è»çÁø ( Kim Sa-Jin ) 
°¡Å縯´ëÇб³ ¼º°¡º´¿ø »êºÎÀΰúÇб³½Ç
³ªÁ¾±¸ ( Rha Jong-Gu ) 
°¡Å縯´ëÇб³ ÀÇ°ú´ëÇÐ »êºÎÀΰúÇб³½Ç
±è¼öÆò ( Kim Soo-Pyung ) 
°¡Å縯´ëÇб³ ÀÇ°ú´ëÇÐ »êºÎÀΰúÇб³½Ç

Abstract

¸ñÀû: ÀÚ°£ÀüÁõÀÇ º´Å»ý¸®¸¦ ±Ù°Å·Î ÇÑ »ýÈ­ÇÐÀû Ç¥Áö¹°Áú·Î¼­ VCAM-1, PDGF-AB, Antithrombin ¥², D-dimerÀÇ ÀÇÀÇ¿Í À¯¿ë¼ºÀ» ¿¬±¸Çϱâ À§ÇÔ.
¹æ¹ý: Á¤»ó»ê¸ð 15·Ê¿Í ÀÚ°£ÀüÁõ 352·ÊÀÇ È¯ÀÚ¿¡¼­ VCAM-1, PDGF-AB, Antithrombin-¥², D-dimerÀÇ Ç÷Àå ³óµµ¸¦ ÃøÁ¤ÇÏ¿© ºñ±³ÇÏ°í ÀÚ°£ÀüÁõ ȯÀÚ¿¡¼­ »êÀü,»êÈÄ ³óµµ¸¦ ºñ±³ÇÏ¿´´Ù. Á¤»ó »ê¸ð¿¡¼­ÀÇ °¢ Ç¥Áö¹°ÁúÀÇ Æò±Õ¡¾2Ç¥ÁØÆíÂ÷ ¶Ç´Â Æò±Õ¡¾1Ç¥ÁØÆíÂ÷ÀÇ ±âÁØ°ªÀ» ±âÁØÀ¸·ÎÇÏ¿© °¢ Ç¥Áö¹°ÁúÀÇ ¹Î°¨µµ, ƯÀ̵µ, ¾ç¼º¿¹Ãø°ª ¹× À½¼º ¿¹Ãø°ªÀ» ±¸ÇÏ¿´´Ù.
°á°ú: VCAM-1, AT-¥², D-dimer°ªÀº Á¤»ó »ê¸ð¿Í ÀÚ°£ÀüÁõ ȯÀÚ »çÀÌ¿¡ À¯ÀÇÇÑ Â÷ÀÌ°¡ ÀÖ¾úÁö¸¸ PDGF-ABÀÇ °ªÀº À¯ÀÇÇÑ Â÷ÀÌ°¡ ¾ø¾ú´Ù. Á¤»ó »ê¸ðÀÇ Æò±Õ ¡¾2Ç¥ÁØÆíÂ÷¸¦ ±âÁØ°ªÀ¸·Î ÇßÀ» ¶§ VCAM-1, AT-¥² ±×¸®°í D=dimer °¢°¢ÀÇ ¹Î°¨µµ´Â 38%, 34% ±×¸®°í 40% ¿´À¸¸ç °¢°¢ÀÇ Æ¯À̵µ´Â 100%, 87% ±×¸®°í 100%, °¢°¢ÀÇ ¾ç¼º¿¹Ãø°ªÀº 100%, 86% ±×¸®°í 100%¿´°í, °¢°¢ÀÇ À½¼º¿¹Ãø°ªÀº 57%, 36% ±×¸®°í 42%¿´´Ù. Á¤»ó»ê¸ðÀÇ Æò±Õ ¡¾1Ç¥ÁØÆíÂ÷¸¦ ±âÁØ°ªÀ¸·Î ÇßÀ» ¶§ VCAM-1, AT-¥² ±×¸®°í D-dimer °¢°¢ÀÇ ¹Î°¨µµ´Â 43%, 51%, 60%ÀÌ°í, °¢°¢ÀÇ Æ¯À̵µ´Â 80%, 87%, 80%ÀÌ´Ù. °¢°¢ÀÇ ¾ç¼º ¿¹Ãø°ªÀº 64%, 90%, 88%ÀÌ°í, °¢°¢ÀÇ À½¼º ¿¹Ãø°ªÀº 50%, 43%, 46%¿´´Ù.
°á·Ð: VCAM-1, AT-¥² ±×¸®°í D-dimer¿Í °°Àº »ýÈ­ÇÐÀû Ç¥Áö¹°ÁúÀÇ Á¶ÇÕÀº ÀÚ°£ÀüÁõ¿¡¼­ »ýÈ­ÇÐÀû Ç¥Áö¹°Áú·Î¼­ À¯¿ëÇÒ °ÍÀ¸·Î »ç·áµÈ´Ù.

Background and Puropse: The pathophysiologic features of preeclampsia are poorly understood. The diagnosis of preeclampsia is based not on the pathophysiology, but on the clinical symptoms. The endothelial dysfunc tion and the intravascular coagulopathy secondary to it, might be pivotal in the pathophysiology of preeclampsia. The purpose of this study is to investigate the significance of the potential biomarkers based on pathophysiology in preeclampsia.
Methods: The vascular cell adhesion molecule-1 (VCAM-1), platelet-derived growth factor (PDGF-AB), antithrombin-IlI (AT-11I) and D-dimer were measured in the plasma of the normotensive pregnant(control group) and preeclamptic women(study group). On the basis of the mean ¡¾2SD or mean ¡¾ ISD cut-off value of biomarkers in control group, the sensitivity, specificity, positive predictive value and negative pred ctive value of each marker were calculated.
Results: There were significant differences in VCAM-1, AT-III and D-dimer between control and study group. But the levels of PDGF were not significantly different from each other. With the mean¡¾2SD cut-off value, the sensitivities of VCAM-1, AT-III and D-dimer were 38%, 34% and 40%, respectively. The specificities of VCAM-1, AT III and D-dimer were 100%, 87% and 100%, respectively. Their positive predictive values were 100%, 86% and 100%, respectively. Their negative predictive values were 57%, 36% and 42%, respectively. With the mean ¡¾1SD cut-off value, the sensitivities of VCAM-1, AT-III and D-dimer were 43% 51% and 60%,respectively Their specificities are 80%, 87% and 80%, respectively. Their positive predictive values were 64%, 90% and 88%, respectively. Their negative predictive values were 50%, 43% and 46%, respectively.
Conclusion: The combination of these biomarkers such as VCAM-1, AT-III and D-dimer may be more useful as a biomarker in preeclampsia.

Å°¿öµå

»ýÈ­ÇÐÀû Ç¥Áö¹°Áú;ÀÚ°£ÀüÁõ;
D-dimer;AT-III;VCAM-1;PDGF;biological markers;preeclampsia

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

   

µîÀçÀú³Î Á¤º¸

KCI
KoreaMed
KAMS